This white paper examines regional differences in oncology treatment plans and how they can shape more informed oncology strategies.
More than half of patients with cancer are treated in community oncology settings, but while pharma leaders have increased their efforts to better reach and engage providers beyond academic medical centers, they may be overlooking important nuances by assuming all community practices are the same.
To better understand these dynamics, Aptitude Health met with hundreds of community oncologists to understand how regional differences shape treatment decision-making.
In this white paper, you’ll learn:
- Regional trends in guidelines alignment, treatment-decision factors and more
- Context around the unique motivations and barriers contributing to regional trends
- How commercial leaders can interpret and activate these insights to inform their oncology strategies